Using tDCS in Speech-based Stroke Rehabilitation

Recruiting N/A Interventional Study
Apraxia of Speech
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
24 (estimated)
Sponsor
NYU Langone Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Right-handed * Monolingual (English) * Single left-hemisphere CVA * A minimum of six months post-stroke * Clinical diagnosis of apraxia of speech * Normal speech perception * Passing score on the hearing screening. Exclusion Criteria: * Diagnosis of laryngeal voice disorder …
Contacts

Buchwald Lab

buchwald-lab@nyu.edu

CONTACT